SCHEMBL535757

SCHEMBL535757

CC(=O)C1CCCOC1=O

nearest known ligand 0.39

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
FKBP1A P62942 3/20 0.36
KDM4E B2RXH2 1/20 0.33
PGR P06401 2/20 0.33
MAPK1 P28482 1/20 0.32
F2 P00734 1/20 0.32
PRSS1 P07477 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3414464 0.94 FKBP1A (0.39) FKBP1AKDM4EPGR
SCHEMBL13827000 0.86
SCHEMBL22587457 0.86
SCHEMBL26922 0.86
SCHEMBL29771045 0.84 MAPK1 (0.36) MAPK1
SCHEMBL10567776 0.80 FKBP1A (0.34) FKBP1A
SCHEMBL2058293 0.78 FKBP1A (0.33) FKBP1A
SCHEMBL2058351 0.78 FKBP1A (0.33) FKBP1A
SCHEMBL2057937 0.78 FKBP1A (0.33) FKBP1A
SCHEMBL2057726 0.78 MMP3 (0.36) FKBP1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120019095-A Curing agent composition for radical-polymerizable resin and radical-polymerizable resin composition 株式会社力森诺科 2025-05-16 CN claimed
WO-2024090516-A1 RADICAL POLYMERIZABLE RESIN CURING AGENT COMPOSITION AND RADICAL POLYMERIZABLE RESIN COMPOSITION 株式会社レゾナック 2024-05-02 WO claimed
CN-114469929-A Medical application of acetyl valeryl triester 上海中医药大学 2022-05-13 CN claimed
CN-120019095-A Curing agent composition for radical-polymerizable resin and radical-polymerizable resin composition 株式会社力森诺科 2025-05-16 CN disclosed
CN-120019095-A Curing agent composition for radical-polymerizable resin and radical-polymerizable resin composition 株式会社力森诺科 2025-05-16 CN disclosed
WO-2024090516-A1 RADICAL POLYMERIZABLE RESIN CURING AGENT COMPOSITION AND RADICAL POLYMERIZABLE RESIN COMPOSITION 株式会社レゾナック 2024-05-02 WO disclosed
WO-2024090516-A1 RADICAL POLYMERIZABLE RESIN CURING AGENT COMPOSITION AND RADICAL POLYMERIZABLE RESIN COMPOSITION 株式会社レゾナック 2024-05-02 WO disclosed
US-20240126170-A1 METHOD OF MANUFACTURING A SEMICONDUCTOR DEVICE AND PHOTORESIST COMPOSITION TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY, LTD. (TW) 2024-04-18 US disclosed
CN-114469929-A Medical application of acetyl valeryl triester 上海中医药大学 2022-05-13 CN disclosed
CN-114469929-A Medical application of acetyl valeryl triester 上海中医药大学 2022-05-13 CN disclosed
EP-1952918-B1 METHOD FOR PRODUCING METAL PARTICLE DISPERSION, CONDUCTIVE INK USING METAL PARTICLE DISPERSION PRODUCED BY SUCH METHOD, AND CONDUCTIVE COATING FILM TOYO INK MFG CO (JP) 2013-05-22 EP disclosed
US-20090258202-A1 Method for Producing Metal Particle Dispersion, Conductive Ink Using Metal Particle Dispersion Produced by Such Method, and Conductive Coating Film GVP GESELLSCHAFT ZUR VERMARKTUNG DER PORENBRENNERTECHNIK MBH (DE) 2009-10-15 US disclosed
US-20090017082-A1 COLORED METALLIC PIGMENT, PROCESS FOR PRODUCING THE SAME, AND COATING COMPOSITION AND COSMETIC PREPARATION CONTAINING SAID COLORED METALLIC PIGMENT TOYO ALUMINIUM KABUSHIKI KAISHA (JP) 2009-01-15 US disclosed
EP-1990377-A1 COLORED METALLIC PIGMENT, PROCESS FOR PRODUCING THE SAME, AND COATING COMPOSITION AND COSMETIC PREPARATION COMPRISING SAID COLORED METALLIC PIGMENT TOYO ALUMINIUM KABUSHIKI KAISHA (JP) 2008-11-12 EP disclosed
EP-1952918-A1 METHOD FOR PRODUCING METAL PARTICLE DISPERSION, CONDUCTIVE INK USING METAL PARTICLE DISPERSION PRODUCED BY SUCH METHOD, AND CONDUCTIVE COATING FILM Toyo Ink Mfg. Co., Ltd (JP) 2008-08-06 EP disclosed
US-20080102377-A1 rechargeable batteries having excellent battery cycle properties, electrical capacity and storage characteristic during charging, comprising electrodes and a nonaqueous electrolytic solution containing a dicarbonyl compound as an additive UBE INDUSTRIES, LTD (JP) 2008-05-01 US disclosed
US-20020091256-A1 Azepine compounds DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 2002-07-11 US disclosed
EP-0030141-B1 HERBICIDAL UREAS AND ISOUREAS, PREPARATION, COMPOSITIONS AND USE THEREOF, INTERMEDIATES THEREFOR AND PREPARATION OF SAID INTERMEDIATES E.I. DU PONT DE NEMOURS AND COMPANY (US) 1984-06-20 EP disclosed
EP-0057546-A2 Sulfonylurea N-oxides E.I. DU PONT DE NEMOURS AND COMPANY (US) 1982-08-11 EP disclosed
US-4132703-A Stabilization of vinyl chloride polymers by means of lactone compounds RHONE-POULENC INDUSTRIES (FR) 1979-01-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020091256-A1 Azepine compounds AZI2, ARL1, APOL1 FKBP1A 4480/4885KDM4E 1359/4885PGR 2563/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.